FDA Bans Generics of Purdue’s Older OxyContin Painkiller

Generic-drug companies will be barred from making copies of older versions of OxyContin that don’t have tamper-resistant qualities, U.S. regulators said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.